GILEAD SCIENCES, INC. Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$1.6T
Holdings
16
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACLXARCELLX INC | 6,720,803 | $515.4B | 33.23% | |
| 2 | GLPGGALAPAGOS NV | 16,707,477 | $461.7B | 29.77% | |
| 3 | RCUSARCUS BIOSCIENCES INC | 30,061,124 | $447.6B | 28.86% | |
| 4 | ASMBASSEMBLY BIOSCIENCES INC | 2,209,471 | $34.9B | 2.25% | |
| 5 | MRUSMERUS N V | 452,527 | $19.0B | 1.23% | |
| 6 | KYTXKYVERNA THERAPEUTICS INC | 4,126,119 | $15.4B | 0.99% | |
| 7 | CYPHLEAP THERAPEUTICS INC | 5,319,148 | $15.3B | 0.99% | |
| 8 | TNGXTANGO THERAPEUTICS INC | 4,854,443 | $15.0B | 0.97% | |
| 9 | XLOXILIO THERAPEUTICS INC | 9,105,451 | $8.7B | 0.56% | |
| 10 | —ALLOVIR INC | 16,635,286 | $7.0B | 0.45% | |
| 11 | HOOKHOOKIPA PHARMA INC | 1,875,945 | $3.8B | 0.24% | |
| 12 | —IKENA ONCOLOGY INC | 2,008,338 | $3.3B | 0.21% | |
| 13 | ALLOALLOGENE THERAPEUTICS INC | 1,156,689 | $2.5B | 0.16% | |
| 14 | BRNSBARINTHUS BIOTHERAPEUTICS PL | 620,351 | $749.4M | 0.05% | |
| 15 | AGENAGENUS INC | 231,663 | $634.8M | 0.04% | |
| 16 | KRON1USDKRONOS BIO INC | 188,567 | $179.1M | 0.01% |